Abstract
The aim of this study was to evaluate how growth factors (PDGF-BB, EGF, and TGF-1β) modulate hyaluronan synthase (HAS) activities in normal or stressed cultured human skin fibroblasts. The effects of concomitant treatment with cytokines and FeSO4 plus ascorbate on HAS mRNA expression, protein synthesis, and hyaluronic acid (HA) concentrations were also studied. Treatment of fibroblasts with growth factors up-regulated HAS gene expression and increased HAS enzymes and HA production. PDGF-BB induced HAS mRNA expression, protein synthesis, and HA production more efficiently than EGF and TGF-1β. EGF was less effective than TGF-1β. In addition, TGF-1β reduced the expression and synthesis of HAS3, while PDGF-BB and EGF had the opposite effect. Concomitant treatment with growth factors and the oxidant was able to further increase HAS mRNA expression, once again with the exception of HAS3 with TGF-1β. HAS protein synthesis was reduced, while HA levels were unaffected in comparison to those obtained from exposure to FeSO4 plus ascorbate alone. In conclusion, although growth factors plus the oxidant synergistically induced HAS mRNA expression in part, enzyme production was not correlated with this increase. Moreover, the increase in HAS mRNA levels was not translated into a consequent rise in HA concentration.
Similar content being viewed by others
Abbreviations
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ECM:
-
extracellular matrix
- EGF:
-
epidermal growth factor
- FBS:
-
fetal bovine serum
- GAGs:
-
glycosaminoglycans
- HA:
-
hyaluronic acid
- HASs:
-
hyaluronan synthases
- HRP:
-
horseradish peroxidase
- IFN-γ:
-
interferon-γ
- IL-1β:
-
interleukin-1β
- NADH:
-
reduced nicotinamide adenine dinucleotide
- PBS:
-
phosphate-buffered saline
- PCR:
-
polymerase chain reaction
- PDGF-BB:
-
platelet derived growth factor BB
- PGs:
-
proteoglycans
- ROS:
-
reactive oxygen species
- SDS:
-
sodium dodecyl sulfate
- TBS:
-
tris-buffered solution
- TGF-1β:
-
transforming growth factor 1β
- TNF-α:
-
tumor necrosis factor α
References
Droge, W. (2002) Physiol. Rev., 82, 47–95.
Templeton, D. M. (1992) Crit. Rev. Clin. Lab. Sci., 29, 141–184.
Laurent, T. C. (1998) The Chemistry, Biology and Medical Application of Hyaluronan and Its Derivatives, Vol. 72, Wenner-Green International Series, Portland Press, London.
Chen, W. Y., and Abatangelo, G. (1999) Wound Rep. Reg., 7, 79–89.
Weigel, P. H., Hascall, V. C., and Tammi, M. (1997) J. Biol. Chem., 272, 13997–14000.
Itano, N., Sawait, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., Miyauchi, S., Spider, P. A., McDonald, A. J., and Kimata, K. (1999) J. Biol. Chem., 274, 25085–25092.
Heldin, P., Laurent, C. T., and Heldin, C. H. (1989) Biochem. J., 258, 919–922.
Jacobson, A., Brinck, J., Briskin, M. J., Spicer, A. P., and Heldin, P. (2000) Biochem. J., 348, 29–35.
Stuhlmeier, K. M., and Pollaschek, C. (2004) J. Biol. Chem., 279, 8753–8760.
Yamada, Y., Itano, N., Hata, K., Ueda, M., and Kimata, K. (2004). J. Invest. Dermatol., 122, 631–639.
Anastassiades, T. P., and Wood, A. (1981) J. Clin. Invest., 68, 792–802.
Whiteside, T. L., Worrall, J. G., Prince, R. K., Buckingham, R. B., and Rodman, G. P. (1985) Arthritis Rheum., 28, 188–197.
Campo, G. M., Avenoso, A., Campo, S., D’Ascola, A., Ferlazzo, A. M., and Calatroni, A. (2006) Mol. Cell. Biochem., 292, 169–178.
Campo, G. M., D’Ascola, A., Avenoso, A., Campo, S., Ferlazzo, A. M., Micali, C., Zanghi, L., and Calatroni, A. (2004) Glycoconj. J., 20, 133–141.
Bustin, S. A. (2000) J. Mol. Endocrinol., 25, 169–193.
Bradford, M. M. (1976) Analyt. Biochem., 72, 248–254.
Iozzo, R. V. (1998) Annu. Rev. Biochem., 67, 609–652.
Knudson, C. B., and Knudson, W. (1993) FASEB J., 7, 1233–1241.
Hascall, V. C., Majors, A. K., De La Motte, C. A., Evanko, S. P., Wang, A., Drazba, J. A., Strong, S. A., and Wight, T. N. (2004) Biochim. Biophys. Acta, 1763, 3–12.
Laurent, T. C., and Fraser, J. R. E. (1991) Catabolism of Hyaluronan, in Degradation of Bioactive Substances: Physiology and Pathology (Henriksen, J. H., ed.) RC Press, Boca Raton, pp. 249–265.
Spicer, A. P., and Nguyen, T. K. (1999) Biochem. Soc. Trans., 27, 109–115.
Laurent, T. C., and Fraser, J. R. E. (1992) FASEB J., 6, 2397–2404.
Iozzo, R. V., and Murdoch, A. D. (1996) FASEB J., 10, 598–614.
Campo, G. M., Avenoso, A., Campo, S., Ferlazzo, A. M., Altavilla, D., and Calatroni, A. (2003) Arthritis Res. Ther., 5, R122–R131.
Campo, G. M., Avenoso, A., D’Ascola, A., Campo, S., Ferlazzo, A. M., Sama, D., and Calatroni, A. (2005) Toxicol. In Vitro, 19, 561–572.
Fukuda, K., Takayama, M., Ueno, M., Oh, M., Asada, S., Kumano, F., and Tanaka, S. (1997) Inflamm. Res., 46, 114–117.
Kvam, B. J., Fragonas, E., Degrassi, A., Kvam, C., Matulova, M., Pollesello, P., Zanetti, F., and Vittur, F. (1995) Exp. Cell Res., 218, 79–86.
Suzuki, Y., and Yamaguchi, T. (1993) Agents Actions, 38, 32–37.
Calatroni, A. (2002) Extraction and Purification of Glycosaminoglycans (GAGs) from Biological Fluids, in Analytical Techniques to Evaluate the Structure and Function of Natural Polysaccharides, Glycosaminoglycans (Volpi, N., ed.) Research Signpost Press, Trivandrum, pp. 15–22.
Calabro, L., Musolino, C., Spatari, G., Vinci, R., and Calatroni, A. (1998) Clin. Chim. Acta, 269, 185–99.
Friman, C., Nordstrom, D., and Eronen, I. (1987) J. Rheumatol., 14, 1132–1134.
Laurent, T. C., Laurent, U. B. G., and Fraser, J. R. E. (1996) Ann. Med., 28, 241–253.
Plevris, J. N., Haydon, G. H., Simpson, K. J., Dawkes, R., Ludlum, C. A., Harrison, D. J., and Hayes, P. C. (2000) Eur. J. Gastroenterol. Hepatol., 12, 1121–1127.
Radhakrishnamurthy, B., Tracy, R. E., Dalferes, Jr., and Berenson, J. R. (1998) Exp. Mol. Pathol., 65, 1–8.
Roughley, P.J. (2001) Arthritis Res., 3, 342–347.
Palladino, Jr., and Shepard, H. M. (1985) Science, 230, 943–945.
Schlessinger, J. (1986) J. Cell. Biol., 103, 2067–2072.
Recklies, A. D., White, C., Melching, L., and Roughley, P. J. (2001) Biochem. J., 354, 17–24.
Sugiyama, Y., Shimada, A., Sayo, T., Sakai, S., and Inoue, S. (1998) J. Invest. Dermatol., 110, 116–121.
Tirone, E., D’Alessandris, C., Hascall, V.C., Siracusa, G., and Salustri, A. (1997) J. Biol. Chem., 272, 4787–4794.
Ducale, A. E., Ward, S. I., Dechert, T., and Yager, T. L. (2005) Am. J. Physiol. Gastrointest. Liver Physiol., 289, G462–G470.
Oguchi, T., and Ishiguro, N. (2004) Connect. Tissue Res., 45, 197–205.
Mata-Greenwood, E., Grobe, A., Kumar, S., Noskina, J., and Black, S. M. (2005) Am. J. Physiol. Lung Cell Mol. Physiol., 289, L288–L289.
Suzuki, Y. J., Nagase, H., Nie, K., and Park, A. M. (2005) Antiox. Redox Signal., 7, 829–834.
Haralson, M. A., and Hassell, J. R. (1995) The Extracellular Matrix: an Overview, in Extracellular Matrix — a Practical Approach (Haralson, M. A., and Hassell, J. R., eds.) IRL Press, New York, pp. 1–30.
Gao, B. (2005) Cell. Mol. Immunol., 2, 92–100.
Tarnawski, A. S. (2005) Dig. Dis. Sci., 50, Suppl. 1, S24–S33.
Wang, J., and Slungaard, A. (2006) Arch. Biochem. Biophys., 445, 256–260.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2007, Vol. 72, No. 9, pp. 1196–1206.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM07-118, July 29, 2007.
Rights and permissions
About this article
Cite this article
Campo, G.M., Avenoso, A., Campo, S. et al. Differential effect of growth factors on hyaluronan synthase gene expression in fibroblasts exposed to oxidative stress. Biochemistry Moscow 72, 974–982 (2007). https://doi.org/10.1134/S0006297907090088
Received:
Issue Date:
DOI: https://doi.org/10.1134/S0006297907090088